Eggerth Alphons

Eggerth Alphons

Auto-generated profile, based on publicly available information

Eggerth Alphons

Digital Health Information Systems, Center for Health & Bioresources, AIT Austrian Institute of Technology GmbH, Austria

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2019 in British Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
AEAlphons Eggerth
Alphons Eggerth
DHDieter Hayn
Dieter Hayn
GSGuenter Schreier
Guenter Schreier
Life expectancy is rising in most parts of the world as is the prevalence of chronic diseases. Suboptimal adherence to long‐term medications is still rather the norm than the exception, although it is well known that suboptimal adherence compromises the therapeutic effectiveness. Information and communications technology provides new concepts for improving adherence to medications. These so‐called telehealth concepts or services help to implement closed‐loop healthcare paradigms and to establish collaborative care networks involving all stakeholders relevant to optimising the overall medication therapy. Together with data from Electronic Health Records and Electronic Medical Records, these networks pave the way to data‐driven decision support systems. Recent advances in machine learning, predictive analytics, and artificial intelligence allow further steps towards fully autonomous telehealth systems. This might bring advances in the future: disburden healthcare professionals from repetitive tasks, enable them to timely react to critical situations, and offer a comprehensive overview of the patients' medication status. Advanced analytics can help to assess whether patients have taken their medications as prescribed, to improve adherence via automatic reminders. Ultimately, all relevant data sources need to be collated into a basis for data‐driven methods, with the goal to assist healthcare professionals in guiding patients to obtain the best possible health status, with a reasonable resource utilisation and a risk‐adjusted safety and privacy approach. This paper summarises the state‐of‐the‐art of telehealth and artificial intelligence applications in medication management. It focuses on 3 major aspects: latest technologies, current applications, and patient related issues.

1 January 2017
Verified
Book Chapter
Open access
PDF file
EAEggerth Alphons
Eggerth Alphons
MRModre-Osprian Robert
Modre-Osprian Robert
DHDieter Hayn
Dieter Hayn
KPKastner Peter
Kastner Peter
PGPÖLzl Gerhard
PÖLzl Gerhard
SGSchreier GÜNter
Schreier GÜNter
Background: Automatic event detection is used in telemedicine based heart failure disease management programs supporting physicians and nurses in monitoring of patients' health data.

1 January 2018
Verified
Book Chapter
Closed access
PDF file
VSVeeranki Sai
Veeranki Sai
DHDieter Hayn
Dieter Hayn
EAEggerth Alphons
Eggerth Alphons
JSJauk Stefanie
Jauk Stefanie
KDKramer Diether
Kramer Diether
SGSchreier GÜNter
Schreier GÜNter
Digitalisation of health care for the purpose of medical documentation lead to huge amounts of data, hence having an opportunity to derive knowledge and associations of different attributes recorded. Many health care events can be prevented when identified. Machine learning algorithms could identify such events but there is ambiguity in understanding the suggestions especially in clinical setup. In this paper we are presenting how we explain the decision based on random forest to health care professionals in the course of the project predicting delirium during hospitalisation on the day of admission.

1 January 2018
Verified
Book Chapter
Open access
PDF file
EAEggerth Alphons
Eggerth Alphons
DHDieter Hayn
Dieter Hayn
VSVeeranki Sai
Veeranki Sai
SJStieg JÖRg
Stieg JÖRg
SGSchreier GÜNter
Schreier GÜNter
Hospital readmissions receive increasing interest, since they are burdensome for patients and costly for healthcare providers. For the calculation of reimbursement fees, in Germany there is the German-Diagnosis Related Groups (G-DRG) system. For every hospital stay, data are collected as a so-called “case”, as the basis for the subsequent reimbursement calculations (“§21 dataset”). Merging rules lead to a loss of information in §21 datasets. We applied machine learning to §21 datasets and evaluated the influence of case merging for the resulting accuracy of readmission risk prediction. Data from 478,966 cases were analysed by applying a random forest. Many cases with readmissions within 30 days had been merged and thus their prediction required additional data. Using 10-fold cross validation, the prediction for readmissions within 31–60 days showed no notable difference in the area under the ROC curves comparing unedited §21 datasets with §21 datasets with restored original cases. The achieved AUC values of 0.69 lie in a similar range as the values of comparable state-of-the-art models. We conclude that dealing with merged cases, i.e. adding data, is required for 30-day-readmission prediction, whereas un-merging brings no improvement for the readmission prediction of period beyond 30 days.